Related Experiment Video
Updated: Jul 20, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
AKT regulation of estrogen receptor beta transcriptional activity in breast cancer
Bich N Duong1, Steven Elliott, Daniel E Frigo
1Center for Bioenvironmental Research, Tulane University, New Orleans, LA, USA.
Abstract:
Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer. Here, we investigated the regulation of the transcriptional activity of the newer ER beta by PI3K-AKT signaling. Tissue arrays of breast cancer specimens showed a positive association between the expressions of AKT and ER beta in the clinical setting. Reporter gene assays using pharmacologic and molecular inhibitors of AKT and constitutively active AKT revealed for the first time the ability of AKT to (a) potentiate ER beta activity and (b) target predominantly the activation function-2 (AF2) domain of the receptor, with a requirement for residue K269. Given the importance of coactivators in ER transcriptional activity, we further investigated the possible involvement of steroid receptor coactivator 1 (SRC1) and glucocorticoid receptor-interacting protein 1 (GRIP1) in AKT regulation of ER beta. Mammalian two-hybrid assays revealed that AKT enhanced both SRC1 and GRIP1 recruitment to the ER beta-AF2 domain, and reporter gene analyses revealed that AKT and GRIP1 cooperatively potentiated ER beta-mediated transcription to a level much greater than either factor alone. Investigations into AKT regulation of GRIP with mammalian one-hybrid assays showed that AKT potentiated the activation domains of GRIP1 itself, and in vitro kinase assays revealed that AKT directly phosphorylated GRIP1. The cross-talk between the PI3K-AKT and ER beta pathways, as revealed by the ability of AKT to regulate several components of ER beta-mediated transcription, may represent an important aspect that may influence breast cancer response to endocrine therapy.
Insights
The AKT pathway enhances estrogen receptor beta (ER beta) activity, particularly its activation function-2 domain, by interacting with coactivators like GRIP1. This cross-talk may impact breast cancer endocrine therapy response.
Area of Science:
- Molecular and Cellular Biology
- Endocrinology
- Oncology
Background:
- Growth factor signaling via the PI3K-AKT pathway influences estrogen receptor alpha (ER alpha) activity and tamoxifen resistance in breast cancer.
- The role of the PI3K-AKT pathway in regulating the transcriptional activity of estrogen receptor beta (ER beta) remains largely unexplored.
Purpose of the Study:
- To investigate the regulation of ER beta transcriptional activity by the PI3K-AKT signaling pathway.
- To elucidate the specific domains and coactivators involved in AKT-mediated ER beta regulation.
Main Methods:
- Analysis of breast cancer tissue arrays to correlate AKT and ER beta expression.
- Reporter gene assays with pharmacologic and molecular AKT inhibitors and activators.
- Mammalian two-hybrid and one-hybrid assays to assess protein-protein interactions and domain activity.
- In vitro kinase assays to determine direct phosphorylation events.
Main Results:
- A positive association between AKT and ER beta expression was observed in clinical breast cancer specimens.
- AKT was found to potentiate ER beta transcriptional activity, primarily through the activation function-2 (AF2) domain, requiring residue K269.
- AKT enhanced the recruitment of coactivators steroid receptor coactivator 1 (SRC1) and glucocorticoid receptor-interacting protein 1 (GRIP1) to ER beta.
- AKT directly phosphorylated GRIP1, and AKT and GRIP1 cooperatively increased ER beta-mediated transcription.
Conclusions:
- The PI3K-AKT pathway directly regulates ER beta transcriptional activity, involving its AF2 domain and coactivators like GRIP1.
- AKT's phosphorylation of GRIP1 and enhanced coactivator recruitment highlight a significant cross-talk between PI3K-AKT and ER beta signaling.
- This intricate cross-talk may represent a critical factor influencing breast cancer progression and response to endocrine therapies.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

